Author: OurCrowd

[IQM in IQM] IQM–OpenOcean–Lakestar State of Quantum 2024: Quantum resilient to investment slowdown with widespread government backing

Jan 29, 2024 |

London, UK, Espoo, Finland, 30 January 2024: Today, IQM Quantum Computers, a global leader in building quantum computers, OpenOcean, a leading European venture capital firm, and Lakestar, the leading European technology investor, have released the OpenOcean–IQM–Lakestar State of Quantum 2024 Report, in association with The Quantum Insider (TQI). The report shows that quantum computing has been resilient to overall downturns in the global economy, with continued growth backed up by strong government backing and continued investment momentum in Europe. Read...

Read More

[Insightec in PR Newswire]  Insightec announces Exablate Prime -the next generation of MR-guided focused ultrasound  

Jan 29, 2024 |

HAIFA, Israel and MIAMI, Jan. 29, 2024 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced its launch of Exablate Prime, a significant enhancement to the Exablate Neuro platform. Based on customer input and feedback, Exablate Prime is the culmination of over 10 years of significant research and development designed to increase precision, efficiency, and experience of the surgeon – and the patient. Read...

Read More

[mPrest in PR Newswire] mPrest selected as DERMS provider for Doral Energy

Jan 28, 2024 |

PETACH TIKVA, Israel, Jan. 28, 2024 /PRNewswire/ — mPrest, a leading developer and provider of dynamic grid aware, as well as Behind the Meter, Distributed Energy Resource Management Systems (DERMS) has been chosen by Doral Energy, a leading global company in the field of renewable energy, as its DERMS platform for the purpose of managing and optimizing its distributed solar and storage assets profits. Read...

Read More

[DailyPay in Newswire] Valor Hospitality Partners Joins Forces With DailyPay, Providing U.S. ‘Hotelitarians’ With Impactful Financial Benefit

Jan 25, 2024 |

NEW YORK, NEW YORK, UNITED STATES, January 25, 2024 /EINPresswire.com/ — Valor Hospitality Partners, a full-service hotel management acquisition and development company, has partnered with DailyPay to provide additional benefits to their employees—known as ‘hotelitarians.’ DailyPay is the leading provider of on-demand pay and through this partnership, Valor’s United States employees have an additional benefit, boosting financial wellness: on-demand pay. Read...

Read More

[Biolojic in Business Wire] First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2 Antibody for Solid Tumor Cancers

Jan 25, 2024 |

LARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today announced dosing of the first patient in the initial Phase 2 expansion cohorts of its Phase 1/2 clinical trial evaluating AU-007 for treatment of unresectable locally advanced or metastatic cancers. AU-007 is a human IgG1 monoclonal antibody designed to harness the power of interleukin-2 (IL-2) to eradicate solid tumors, and the first AI-designed human monoclonal antibody to be tested in a clinical trial. Phase 1 data demonstrate that AU-007 is currently the only IL-2 agent that can reduce regulatory T cells (Tregs), which suppress the immune system. Read...

Read More